Triple
T6064893
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Mounjaro |
E135131
|
entity |
| Predicate | hasPharmacologicalClass |
P24600
|
FINISHED |
| Object | dual GIP and GLP-1 receptor agonist |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: dual GIP and GLP-1 receptor agonist | Statement: [Mounjaro, hasPharmacologicalClass, dual GIP and GLP-1 receptor agonist]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasPharmacologicalClass Context triple: [Mounjaro, hasPharmacologicalClass, dual GIP and GLP-1 receptor agonist]
-
A.
hasPharmacologicClass
chosen
Indicates that a drug or medicinal product belongs to a specific pharmacologic class based on its mechanism of action or therapeutic effect.
-
B.
drugClass
Indicates that one entity is classified as a particular pharmacological or therapeutic category of drugs in relation to another entity.
-
C.
hasChemicalClass
Indicates that an entity belongs to, or is categorized under, a particular chemical class based on its structural or compositional characteristics.
-
D.
protectedDrugClassesInclude
Indicates that the specified set of protected drug classes includes the referenced drug class or classes.
-
E.
hasPharmacologicalEffect
Indicates that one entity produces a specific pharmacological effect or action on another entity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00878d06881909ee78e88913bf890 |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c05723c91c819090b4d4672e72f9f3 |
completed | March 22, 2026, 8:54 p.m. |
| PD | Predicate disambiguation | batch_69c049f031408190b08b2766237c5dd0 |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:10 p.m.